Hot Features
Premium
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Period:
Draw Mode:
| Volume | 0 |
|
|||||
| News | - | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Qualigen Therapeutics Inc | QLGN | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 0.199 | 19:00:00 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 0.199 |
| Trades | Shares Traded | Average Volume | 52 Week Range |
|---|---|---|---|
| 0 | 0 | - | 0.181 - 1.26 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| - | 0 | US$ 0.199 | USD |
Qualigen Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 2.33M | 5.18M | - | 0 | -13.42M | -2.59 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Qualigen Therapeutics News
| Date | Time | Source | News Article |
|---|---|---|---|
| 5/30/2024 | 15:00 | Edgar (US Regulatory) | Form 8-K - Current report |
| 5/30/2024 | 15:00 | GlobeNewswire Inc. | Qualigen Therapeutics, Inc. Received Nasdaq Notice of a.. |
| 5/14/2024 | 15:05 | Edgar (US Regulatory) | Form NT 10-Q - Notification of inability to timely file Form.. |
| 5/03/2024 | 19:59 | Edgar (US Regulatory) | Form S-1/A - General form for registration of securities.. |
| 4/16/2024 | 06:00 | GlobeNewswire Inc. | Marizyme Enters Into Co-Development Agreement With Qualigen.. |
| 4/10/2024 | 07:00 | GlobeNewswire Inc. | Qualigen Therapeutics' Novel Direct Pan-RAS Inhibitors.. |
| 4/09/2024 | 07:00 | GlobeNewswire Inc. | Qualigen Therapeutics Announces Poster Featuring Positive.. |
| 2/27/2024 | 06:00 | Edgar (US Regulatory) | Form 8-K - Current report |
| 2/22/2024 | 15:10 | Edgar (US Regulatory) | Form 8-K - Current report |
| 12/07/2023 | 15:15 | Edgar (US Regulatory) | Form 8-K - Current report |
| 11/22/2023 | 15:30 | Edgar (US Regulatory) | Form 8-K - Current report |
| 11/14/2023 | 15:30 | GlobeNewswire Inc. | Qualigen Therapeutics Provides Corporate Update for Third.. |
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical QLGN Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.205 | 0.22 | 0.1881 | 0.199334 | 138,773 | -0.006 | -2.93% |
| 1 Month | 0.3076 | 0.33 | 0.181 | 0.2524844 | 304,466 | -0.1086 | -35.31% |
| 3 Months | 0.39 | 0.445 | 0.181 | 0.2824656 | 160,457 | -0.191 | -48.97% |
| 6 Months | 0.6069 | 0.61 | 0.181 | 0.3353568 | 103,237 | -0.4079 | -67.21% |
| 1 Year | 0.95 | 1.26 | 0.181 | 0.4415343 | 61,573 | -0.751 | -79.05% |
| 3 Years | 21.10 | 31.20 | 0.181 | 15.77 | 977,674 | -20.90 | -99.06% |
| 5 Years | 72.50 | 79.00 | 0.181 | 24.51 | 1,085,599 | -72.30 | -99.73% |
Qualigen Therapeutics Description
| Qualigen Therapeutics Inc is a biotechnology company focused on the development and commercialization of novel therapeutic products for the treatment of cancer and infectious diseases using nanoparticle coating technology. |
